Stakeholders submit over 500 comments urging FDA to shape regulation of generative AI medical devices
read at raps ↗RegulatoryNeutral
Over 500 comments have been filed in response to the FDA's discussion paper on generative AI-enabled medical devices.
The feedback reflects a wide range of viewpoints. Some participants recommend a flexible, risk-based regulatory approach, while others argue for stricter oversight to protect patient safety and ensure efficacy.
The FDA must now consider this diverse input as it crafts a regulatory framework for emerging AI-driven diagnostic and therapeutic tools.
source
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “Stakeholders offer competing feedback on how FDA should regulate genAI devices”
read at raps ↗
comments(0)
5-min edit window · permanent after that